Tag - ADXS

Developments

Advaxis and Biosight in merger pact

Advaxis (NASDAQ:ADXS) and closely-held Biosight of Israel entered into a definitive merger agreement, with shareholders of Biosight becoming the majority holders of the combined company. Advaxis will be renamed Biosight...

July 7, 2021

Developments

Advaxis reports positive initial Phase 1 data for cancer vaccine

Advaxis’ (NASDAQ:ADXS) ADSX-NEO has demonstrated significant anti-tumor activity in a Phase 1 study of patients with certain types of advanced or metastatic solid tumors. ADXS-NEO is a live, attenuated Listeria...

April 2, 2019

Feature

Advaxis readies cervical cancer pivotal trial

By Len Zehr Advaxis (NASDAQ:ADXS) hopes to begin a registration trial before the end of the year with its next-generation immunotherapy, ADXS-HPV, for the treatment of invasive cervical cancer. “We are pleased with the...

February 25, 2014

Tag - ADXS

Advaxis and Biosight in merger pact

Advaxis reports positive initial Phase 1 data for cancer vaccine

Advaxis readies cervical cancer pivotal trial

General

More